This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Mcgill University, Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement, National Institute for Agricultural Research. Active years: 2021.
Company Filing History:
2 out of 570 
1 out of 49 
1 out of 285 
Years Active: 2021
Title: Anne Lespine: Innovator in Parasitic Infection Treatment
Introduction
Anne Lespine is a prominent inventor based in Toulouse, France. She has made significant contributions to the field of pharmacology, particularly in the treatment of parasitic infections. With a focus on enhancing drug efficacy, her work has garnered attention in the scientific community.
Latest Patents
Anne Lespine holds 2 patents related to the use of avermectin derivatives. Her latest patents involve the use of these derivatives to increase the bioavailability and efficacy of macrocyclic lactones. The inventions detail the use of avermectin derivatives as drugs for treating parasitic infections, highlighting their potential as inhibitors of membrane-bound proteins that transport exogenous compounds out of target cells.
Career Highlights
Throughout her career, Anne has worked with esteemed institutions such as the Royal Institution for the Advancement of Learning / McGill University and the Institut National de Recherche Pour L'Agriculture, L'Alimentation Et L'Environnement. Her research has focused on innovative solutions to combat parasitic diseases, showcasing her dedication to improving health outcomes.
Collaborations
Anne has collaborated with notable colleagues, including Roger Prichard and Cecile Menez. These partnerships have contributed to her research and the advancement of her inventions.
Conclusion
Anne Lespine's work in the field of parasitic infection treatment exemplifies her commitment to innovation and scientific advancement. Her contributions continue to impact the medical community positively.